Cannabicyclol (CBL) is a non-psychoactive cannabinoid. It is one of over one hundred known compounds found within cannabis sativa. There is not a lot of information about this mysterious cannabinoid, so we don’t’ know yet what its effects on the human body might be. However, there is plenty of information known about how it is formed.
The only difference between CBL and the tetrahydrocannabinol (THC) molecule structure is the fact that there is a missing double bond within the second molecule. The acidic parent cannabinoid of CBL, cannabicyclolic acid (CBLa) is formed from the degradation of a compound. Degradation occurs when a compound is exposed to oxygen or UV light. Once cannabichrome carboxylic acid (CBCa) endures the process of degradation, CBLa is formed.
Cannabis generally produces low levels of CBL. However, higher levels of CBL are found within CBD strains. An interesting fact about CBL is that it is difficult for CBLa to decarboxylate into CBL. The process of decarboxylation is when a compound is exposed to UV lights or oxygen. Once it is exposed, it is not an acidic compound anymore. CBL is one of the most resistant cannabinoids when going through this process.
Though there is not much research on the possible benefits CBL holds, like all of the minor cannabinoids, further studies could unearth some remarkable information. Until then, we will have to wait and see.